Author(s): P. V. Adsule, D. V. Purandare, A. R. Chabukswar, R. Nanaware, P. D. Lokhande

Email(s): prajakta.adsule81@gmail.com

DOI: 10.52711/0974-360X.2024.00156   

Address: P. V. Adsule1*, D. V. Purandare1, A. R. Chabukswar1, R. Nanaware1, P. D. Lokhande2
1School of Health Sciences and Technology, Department of Pharmaceutical Sciences, Dr. Vishwanath Karad MIT World Peace University, Pune – 411038.
2Department of Chemistry, Savitribai Phule Pune University, Pune 411007.
*Corresponding Author

Published In:   Volume - 17,      Issue - 3,     Year - 2024


ABSTRACT:
Breast cancer has been predicted to impact over 2.3 million women annually, with 685,000 deaths occurring out of this condition globally. Breast cancer initially appears in the epithelial cells of channels or lobules of breast glandular tissue whereas less commonly from the basal cells outer layer. Even though some inhibitors have demonstrated anti-breast cancer cell activity, resistance to existing inhibitors and their severe side effects have forced to develop new derivatives. Coumarin nucleoside derivatives were therefore studied in silico, and their effectiveness against cancer cells was found. The studies consisted of ADMET properties, target prediction, MD stimulation, and drug-likeliness characterises. Out of the 12 compounds studied, compounds 2 and 4 were found most potent with binding energy (-7.091 and -7.018kcal/mol respectively). The standard erlotinib (AQ4) with a binding energy of -8.614 kcal/mol.


Cite this article:
P. V. Adsule, D. V. Purandare, A. R. Chabukswar, R. Nanaware, P. D. Lokhande. Designing of Coumarin molecules as EGFR inhibitors and their ADMET, MD Simulation Studies for Evaluating potential as Anticancer molecules. Research Journal of Pharmacy and Technology. 2024; 17(3):1008-4. doi: 10.52711/0974-360X.2024.00156

Cite(Electronic):
P. V. Adsule, D. V. Purandare, A. R. Chabukswar, R. Nanaware, P. D. Lokhande. Designing of Coumarin molecules as EGFR inhibitors and their ADMET, MD Simulation Studies for Evaluating potential as Anticancer molecules. Research Journal of Pharmacy and Technology. 2024; 17(3):1008-4. doi: 10.52711/0974-360X.2024.00156   Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2024-17-3-7


REFERENCES:
1.    Brenda Ernst et al. Immunotherapy for the Treatment of Breast Cancer. Springer. 2015; 17(5). doi:10.1007/s11912-014-0426-9
2.    Catherine M. Bender et al. Cognitive Function and Reproductive Hormones in Adjuvant Therapy for Breast Cancer: A Critical Review. Journal of Pain and Symptom Management. 2001; 21(5): 407-24. doi: 10.1016/s0885-3924(01)00268-8
3.    Jayashree V et al. Breast Cancer and various Prognostic Biomarkers for the diagnosis of the disease: A Review. Research Journal of Pharmacy and Technology. 2017; 10(9): 3211-3216. doi: 10.5958/0974-360X.2017.00570.4  
4.    Alrubaye Yasir S J et al.. Exosome and breast cancer. Research Journal of Pharmacy and Technology. 2022; 15(3): 1393-1397. doi:10.52711/0974-360X.2022.00232
5.    Bhasker S et al. Future of Cancer Therapy-COX-2 Inhibitors: A Review. Research Journal of Pharmacy and Technology. 2009; 2(4): 617- 620.
6.    Kokulwar P. U et al. Microbubble Ultrasound: A Novel Approach in Cancer Therapy. Research Journal of Pharmacy and Technology. 2013; 6(11): 1279-1284.
7.    Kalyankar T. M et al. Application of Nanotechnology in Cancer Treatment. Research Journal of Pharmacy and Technology. 2012; 5(9): 1161- 1167.  https://doi.org/10.1007/978-981-10-4702-2_10
8.    Rao S. Venkateswara et al. Nanocarrier Based Anticancer Drug Delivery System: Current Trends and Prospects. Research Journal of Pharmacy and Technology. 2017; 10(1): 330-336. doi:10.5958/0974-360X.2017.00067.1
9.    Blanca Prieto-Callejero et al. Relationship between chemotherapy-induced adverse reactions and health-related quality of life in patients with breast cancer. Medicine. 2020; 99(33): e21695. doi: 10.1097/MD.0000000000021695
10.    Mishra Rakhi et al. Computational Docking Technique for Drug Discovery: A Review. Research Journal of Pharmacy and Technology. 2021; 14(10): 5558- 5562. doi: 10.52711/0974-360X.2021.00968
11.    Bhat K. Ishwar et al. Synthesis and Antidiabetic Evaluation of Some New Coumarin Coupled 4-Thiazolidinone Derivatives. Research Journal of Pharmacy and Technology. 2019; 12(1): 5215-5218. doi:10.5958/0974-360X.2019.00902.8
12.    Abhishek Kumar et al. Coumarins as Potential Anticoagulant Agents. Research Journal of Pharmacy and Technology. 2022; 15(4): 1659-1663. doi:10.52711/0974-360X.2022.00277
13.    Shah V. V et al. Microwave assisted synthesis of novel Coumarin derivatives for its Anti-Inflammatory applications. Research Journal of Pharmacy and Technology. 2020; 13(6): 2906-2911. doi:10.5958/0974-360X.2020.00518.
14.    Kumar Abhishek et al. Synthesis and Antimicrobial Evaluation of Some Novel Derivatives of Coumarin Moiety. Research Journal of Pharmacy and Technology. 2016; 9(5): 545-548. doi:10.5958/0974-360X.2016.00103.7
15.    Thomas Reshma et al. In silico Docking Approach of Coumarin Derivatives as an Aromatase Antagonist. Research Journal of Pharmacy and Technology. 2015; 8(12): 1673-1678. doi:10.5958/0974-360X.2015.00302.9
16.    Prajakta Adsule et al.  Design, Synthesis and Antibacterial, Antifungal Activity of Some Coumarin Aceto hydrazide Derivatives. Research Journal of Pharmacy and Technology. 2021; 14(7): 3931-7. doi: 10.52711/0974-360X.2021.00683


Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available